Validation of Cxbladder® Triage and Monitor as an Adjunct to Urothelial Carcinoma Diagnosis and Surveillance in a Single Centre
We have validated the use of Cxbladder as an adjunct in the investigation and surveillance of UC. It is a non-invasive, accurate and reproducible test that can aid in ruling out UC, specifically for low-risk patients.
Authors
- Daniel Magee
- Yuigi Yuiminaga
- Ninan Tharakan
Institutions
- Royal Perth Hospital (AU)
Publication Details
- Journal
- Research and Reports in Urology
- Published
- 2025-03-01
- DOI
- https://doi.org/10.2147/rru.s516994
- Citations
- 2
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 4.01